Iambic Therapeutics, a Phase 1 biotech using its AI platform to develop small molecule cancer therapies, raised $150 million ...

Amaero, a producer of titanium and refractory metal powders for defense and aerospace 3D printing, raised $20 million in its ...

Tungsten prices have soared over the past two years amid supply constraints, spurring miners to tap public markets.

EuroSPAC Acquisition, a blank check company led by the CEO of shipping company Euroseas targeting the industrials sector, ...

Hall Chadwick Acquisition II, a blank check company targeting critical materials, infrastructure, and defense, lowered the ...

City Therapeutics, a Phase 1 biotech developing RNA interference therapies for thromboembolic diseases, announced terms for ...

Latest Listings: Africa-focused fintech Airtel Africa ($700mm) completed London's largest IPO since 2021, but broke issue on ...

Retension Pharmaceuticals, a Phase 2b biotech developing an in-licensed treatment for hypertension, raised $45 million by ...

Two biotechs priced IPOs this past week and more joined the pipeline, along with a billion-dollar data center developer, an emerging markets fintech, and a dental treatment company.Autoimmune biotech ...

FireFly Robotics, which makes robotic turfgrass harvesters and autonomous golf course mowers, filed on Wednesday with the SEC ...

Iambic Therapeutics, a Phase 1 biotech using its AI platform to develop small molecule cancer therapies, announced terms for ...

No IPOs are currently scheduled for the week ahead, signaling a quiet start to the fourth quarter.A few companies are eligible to launch in the coming week, including neocloud firm Nscale (NSCL).